Home > Products > HER3 & IGF1R
> Recombinant Anti-HER3 x Anti-IGF1R Bispecific Antibody (sdAb-IgG)
Recombinant Anti-HER3 x Anti-IGF1R Bispecific Antibody (sdAb-IgG) (CAT#: BSSG-406)
Recombinant Anti-HER3 x Anti-IGF1R Bispecific Antibody (sdAb-IgG) is formed by an IgG and two single domains antibodies (sdAbs). The sdAbs from an anti-IGF1R antibody variable domain are respectively connected to the N terminus of the anti-HER3 IgG heavy chains or light chains to form sdAb-(H)IgG or sdAb-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Pancreatic cancer; Hepatocellular carcinoma (HCC) therapy.
There are currently no customer reviews or questions for Recombinant Anti-HER3 x Anti-IGF1R Bispecific Antibody (sdAb-IgG) (BSSG-406). Click the button below to contact us or submit your feedback about this product.